These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 22832942)

  • 1. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.
    Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P
    Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.
    Jensen CD; Steval A; Partington PF; Reed MR; Muller SD
    J Bone Joint Surg Br; 2011 Jan; 93(1):91-5. PubMed ID: 21196550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
    Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R
    Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty.
    Zou Y; Tian S; Wang Y; Sun K
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):660-4. PubMed ID: 24695091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
    Huisman MV; Quinlan DJ; Dahl OE; Schulman S
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment.
    Turpie AG; Haas S; Kreutz R; Mantovani LG; Pattanayak CW; Holberg G; Jamal W; Schmidt A; van Eickels M; Lassen MR
    Thromb Haemost; 2014 Jan; 111(1):94-102. PubMed ID: 24154549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
    Rath NK; Goodson MW; White SP; Forster MC
    Knee; 2013 Dec; 20(6):397-400. PubMed ID: 23566737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
    Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
    J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban: new drug. After hip or knee replacement surgery: LMWH is safer.
    Prescrire Int; 2009 Aug; 18(102):151-3. PubMed ID: 19743567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
    Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
    Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
    Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
    Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.